The Challenge
Sanner recently partnered with a client who delivers a treatment for a chronic disease at a critical transition point. With their existing device approaching end of life, the client needed a clear view of the current market landscape and a robust understanding of viable alternatives to ensure continuity of care for a small but highly dependent patient population.
Our team conducted a thorough tech scouting and landscape review of drug delivery devices relevant to this therapy. This included assessing existing on-market solutions, emerging technologies, and adjacent delivery strategies, alongside their suitability for the specific clinical, regulatory, and user requirements.
Our Approach
Through this research, we helped the client understand the key compromises involved in meeting niche requirements while improving the user experience, also identifying where alternative products could offer new opportunities. We compared options to present different strategies for sustaining treatment access and enhancing daily usability for patients and caregivers.
The Result
This structured comparison enabled our client to make informed decisions about next steps, reducing risk while focusing investment on the most promising opportunities. Ultimately, the work supports their goal of continuing effective treatment for a small population, while evolving their product portfolio to better meet real-world user needs.
If you’d like to learn more about how Sanner supports tech scouting, medical device strategy, or end-of-life product transitions, we’d be happy to talk.
